Advanced
  Home Compare Reports

Comparison with Similar Reports

Blood Collection Devices Market by Product (Tubes (Plasma (EDTA, Heparin), Serum), Needles & Syringes, Blood Bags, Monitors), Method (Manual, Automate...

Publisher:        MarketsandMarkets

# of Pages:        321

Rating: 

1 User License $4,950

Publication Date:  January, 2022

Price:       $4,950 / User License




1 INTRODUCTION 44
1.1 OBJECTIVES OF THE STUDY 44
1.2 MARKET DEFINITION 44
1.2.1 INCLUSIONS & EXCLUSIONS 44
1.3 MARKET SCOPE 45
1.3.1 MARKETS COVERED 45
1.3.2 YEARS CONSIDERED FOR THE STUDY 45
1.4 CURRENCY 46
TABLE 1 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD 46
1.5 LIMITATIONS 46
1.6 STAKEHOLDERS 46
1.7 SUMMARY OF CHANGES 47
2 RESEARCH METHODOLOGY 48
2.1 RESEARCH DATA 48
FIGURE 1 RESEARCH DESIGN 48
2.1.1 SECONDARY DATA 49
2.1.1.1 Key data from secondary sources 50
2.1.2 PRIMARY DATA 50
FIGURE 2 PRIMARY SOURCES 51
2.1.2.1 Key data from primary sources 52
2.1.2.2 Key industry insights 53
2.1.2.3 Breakdown of primary interviews: By company type, designation,
and region 53
2.2 MARKET SIZE ESTIMATION 54
FIGURE 3 REVENUE SHARE ANALYSIS ILLUSTRATION: BECTON, DICKINSON AND COMPANY 54
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
(SUPPLY SIDE): COLLECTIVE REVENUE OF BLOOD COLLECTION PRODUCTS AND METHODS 55
FIGURE 5 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS 56
FIGURE 6 TOP-DOWN APPROACH 57
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 58
FIGURE 7 DATA TRIANGULATION METHODOLOGY 58
2.4 MARKET SHARE ANALYSIS 58
2.5 ASSUMPTIONS FOR THE STUDY 59
2.6 LIMITATIONS 59
2.6.1 METHODOLOGY-RELATED LIMITATIONS 59
2.7 RISK ASSESSMENT 60
TABLE 2 RISK ASSESSMENT: BLOOD COLLECTION DEVICES MARKET 60
2.8 COVID-19 HEALTH ASSESSMENT 60
2.9 COVID-19 ECONOMIC ASSESSMENT 60
2.10 ASSESSMENT OF THE IMPACT OF COVID-19 ON ECONOMIC SCENARIO 61
FIGURE 8 CRITERIA IMPACTING THE GLOBAL ECONOMY 61
3 EXECUTIVE SUMMARY 63
FIGURE 10 BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2021 VS. 2026 (USD MILLION) 63
FIGURE 11 BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2021 VS. 2026 (USD BILLION) 64
FIGURE 12 BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2021 VS. 2026 (USD MILLION) 64
FIGURE 13 BLOOD COLLECTION DEVICES MARKET, BY END USER,
2021 VS. 2026 (USD MILLION) 65
FIGURE 14 BLOOD COLLECTION DEVICES MARKET, BY REGION,
2021 VS. 2026 (USD BILLION) 66
4 PREMIUM INSIGHTS 67
4.1 BLOOD COLLECTION DEVICES MARKET OVERVIEW 67
FIGURE 15 INCREASING DISEASE INCIDENCE AND DEMAND FOR BLOOD COMPONENTS TO DRIVE MARKET GROWTH 67
4.2 BLOOD COLLECTION DEVICES MARKET BY BLOOD COLLECTION TUBES, BY TYPE,
2021 VS. 2026 (USD MILLION) 68
FIGURE 16 PLASMA WHOLE /BLOOD TUBES SEGMENT TO REGISTER THE HIGHEST CAGR 68
4.3 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY METHOD AND COUNTRY (2020) 68
FIGURE 17 MANUAL BLOOD COLLECTION TO ACCOUNT FOR THE LARGEST SHARE OF
THE NORTH AMERICAN MARKET 68
4.4 BLOOD COLLECTION DEVICES MARKET, BY END USER, 2021–2026 69
FIGURE 18 HOSPITALS, AMBULATORY SURGICAL CENTERS, & NURSING HOMES SEGMENT TO WITNESS THE HIGHEST GROWTH 69
4.5 BLOOD COLLECTION DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 69
FIGURE 19 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH IN THE BLOOD COLLECTION DEVICES MARKET 69
5 MARKET OVERVIEW 70
5.1 INTRODUCTION 70
5.2 MARKET DYNAMICS 70
FIGURE 20 BLOOD COLLECTION DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 70
5.2.1 MARKET DRIVERS 71
5.2.1.1 Rising prevalence of infectious diseases with the emergence of newer pathogens and chronic & lifestyle diseases 71
5.2.1.2 Increasing number of hospitals and surgical centers 72
5.2.1.3 Rising number of accidents and trauma cases 72
5.2.1.4 Growing emergence of liquid biopsy tests 72
5.2.1.5 Rising demand and awareness for blood donations and blood components 73
TABLE 3 GLOBAL CANCER PREVALENCE, 2018 VS. 2025 73
5.2.2 RESTRAINTS 75
5.2.2.1 Rising costs of automated blood collection devices 75
5.2.3 OPPORTUNITIES 75
5.2.3.1 Increasing demand for apheresis 75
5.2.3.2 Growing number of emerging economies offer lucrative opportunities 75
5.2.3.3 Rising advancements in blood collection—microsampling and dried blood sampling 76
5.2.4 CHALLENGES 76
5.2.4.1 Increasing complexities of storage and shipping 76
5.2.4.2 Increasing incidences in the lack of skilled professionals 77
5.3 IMPACT OF COVID-19 ON THE BLOOD COLLECTION DEVICES MARKET 77
5.4 RANGES/SCENARIOS 78
5.4.1 BLOOD COLLECTION DEVICES MARKET 78
FIGURE 21 PESSIMISTIC SCENARIO 78
FIGURE 22 OPTIMISTIC SCENARIO 79
FIGURE 23 REALISTIC SCENARIO 79
5.5 REGULATORY ANALYSIS 80
TABLE 4 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING MEDICAL DEVICES 80
5.5.1 NORTH AMERICA 81
5.5.1.1 US 81
5.5.1.2 Canada 81
5.5.2 EUROPE 81
5.5.3 ASIA PACIFIC 81
5.5.3.1 Japan 81
5.5.3.2 India 81
5.5.4 LATIN AMERICA 82
5.5.4.1 Brazil 82
5.5.5 MIDDLE EAST 82
5.6 PORTER’S FIVE FORCES ANALYSIS 83
TABLE 5 BLOOD COLLECTION DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 83
5.6.1 THREAT OF NEW ENTRANTS 83
5.6.2 THREAT OF SUBSTITUTES 83
5.6.3 BARGAINING POWER OF BUYERS 83
5.6.4 BARGAINING POWER OF SUPPLIERS 83
5.6.5 DEGREE OF COMPETITION 83
5.7 TECHNOLOGY ANALYSIS 84
5.8 VALUE CHAIN ANALYSIS 85
FIGURE 24 MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASE 85
5.9 SUPPLY CHAIN ANALYSIS 86
FIGURE 25 BLOOD COLLECTION DEVICES MARKET: SUPPLY CHAIN ANALYSIS 87
5.10 ECOSYSTEM ANALYSIS 87
FIGURE 26 BLOOD COLLECTION DEVICES MARKET: ECOSYSTEM ANALYSIS 88
5.10.1 ROLE IN THE ECOSYSTEM 88
FIGURE 27 KEY PLAYERS IN THE BLOOD COLLECTION DEVICES MARKET 89
5.11 PATENT ANALYSIS 90
5.11.1 PATENT GRANTED TRENDS FOR BLOOD COLLECTION 90
FIGURE 28 PATENT GRANTED TRENDS OF BLOOD COLLECTION TUBES,
JANUARY 2011–JULY 2021 90
FIGURE 29 PATENT GRANTED TRENDS OF BLOOD COLLECTION SYSTEMS/MONITORS, JANUARY 2011– DECEMBER 2021 91
5.11.2 JURISDICTION AND TOP APPLICANT ANALYSIS 91
FIGURE 30 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR BLOOD COLLECTION TUBES PATENTS, JANUARY 2011—NOVEMBER 2021 92
FIGURE 31 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR BLOOD COLLECTION SYSTEMS/MONITORS PATENTS,
JANUARY 2011— DECEMBER 2021 93
5.12 TRADE ANALYSIS 94
TABLE 6 IMPORT DATA FOR HS CODE 901890 - INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES, BY COUNTRY, 2016–2020 (USD MILLION) 94
TABLE 7 EXPORT DATA FOR HS CODE 901890 - INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES, BY COUNTRY, 2016–2020 (USD MILLION) 94
5.13 PRICING ANALYSIS 95
TABLE 8 PRICE RANGE FOR BLOOD COLLECTION DEVICES, BY COUNTRY 95
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 97
5.14.1 REVENUE SOURCES ARE SHIFTING TOWARD TECHNOLOGY-BASED SOLUTIONS DUE TO THE COVID-19 PANDEMIC 97
FIGURE 32 REVENUE SHIFT FOR THE BLOOD COLLECTION DEVICES MARKET 97
6 BLOOD COLLECTION DEVICES MARKET, BY PRODUCT 98
6.1 INTRODUCTION 99
TABLE 9 BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 99
TABLE 10 BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 99
6.2 BLOOD COLLECTION TUBES 100
6.2.1 IMPACT OF COVID-19 ON THE BLOOD COLLECTION TUBES MARKET 100
6.2.2 BLOOD COLLECTION TUBES MARKET, BY TYPE 100
TABLE 11 BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017–2020 (USD MILLION) 100
TABLE 12 BLOOD COLLECTION TUBES MARKET, BY TYPE, 2021–2026 (USD MILLION) 101
TABLE 13 BLOOD COLLECTION TUBES MARKET, BY REGION,
2017–2020 (USD MILLION) 101
TABLE 14 BLOOD COLLECTION TUBES MARKET, BY REGION,
2021–2026 (USD MILLION) 101
6.2.2.1 Plasma/whole-blood tubes 102
TABLE 15 PLASMA/WHOLE-BLOOD TUBES AVAILABLE IN THE MARKET 102
TABLE 16 PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE,
2017–2020 (USD MILLION) 103
TABLE 17 PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE,
2021–2026 (USD MILLION) 103
TABLE 18 PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY REGION,
2017–2020 (USD MILLION) 103
TABLE 19 PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY REGION,
2021–2026 (USD MILLION) 104
6.2.2.1.1 EDTA tubes 104
6.2.2.1.1.1 EDTA tubes to hold the largest share of the plasma/whole blood collection tubes segment 104
TABLE 20 EDTA TUBES AVAILABLE IN THE MARKET 104
TABLE 21 EDTA TUBES MARKET, BY REGION, 2017–2020 (USD MILLION) 105
TABLE 22 EDTA TUBES MARKET, BY REGION, 2021–2026 (USD MILLION) 105
6.2.2.1.2 Heparin tubes 105
6.2.2.1.2.1 Heparin tubes to eliminate the need to wait for clots to form 105
TABLE 23 HEPARIN TUBES AVAILABLE IN THE MARKET 106
TABLE 24 HEPARIN TUBES MARKET, BY REGION, 2017–2020 (USD MILLION) 106
TABLE 25 HEPARIN TUBES MARKET, BY REGION, 2021–2026 (USD MILLION) 106
6.2.2.1.3 Coagulation tubes 107
6.2.2.1.3.1 Coagulation tubes to show high demand for specific tubes 107
TABLE 26 COAGULATION TUBES AVAILABLE IN THE MARKET 107
TABLE 27 COAGULATION TUBES MARKET, BY REGION, 2017–2020 (USD MILLION) 107
TABLE 28 COAGULATION TUBES MARKET, BY REGION, 2021–2026 (USD MILLION) 108
6.2.2.1.4 Glucose tubes 108
6.2.2.1.4.1 Increasing incidence of diabetes to drive the growth of the glucose tubes market 108
TABLE 29 GLUCOSE TUBES AVAILABLE IN THE MARKET 108
TABLE 30 GLUCOSE TUBES MARKET, BY REGION, 2017–2020 (USD MILLION) 109
TABLE 31 GLUCOSE TUBES MARKET, BY REGION, 2021–2026 (USD MILLION) 109
6.2.2.1.5 ESR tubes 109
6.2.2.1.5.1 Increasing prevalence of prominent diseases to support market growth 109
TABLE 32 ESR TUBES AVAILABLE IN THE MARKET 110
TABLE 33 ESR TUBES MARKET, BY REGION, 2017–2020 (USD MILLION) 110
TABLE 34 ESR TUBES MARKET, BY REGION, 2021–2026 (USD MILLION) 110
6.2.2.2 Serum tubes 111
6.2.2.2.1 Accuracy and stability are important advantages of using serum tubes 111
TABLE 35 SERUM TUBES AVAILABLE IN THE MARKET 111
TABLE 36 SERUM TUBES MARKET, BY REGION, 2017–2020 (USD MILLION) 112
TABLE 37 SERUM TUBES MARKET, BY REGION, 2021–2026 (USD MILLION) 112
6.2.3 BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE 112
6.2.3.1 Impact of COVID-19 on the blood collection tubes market, by system type 112
TABLE 38 BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2017–2020 (USD MILLION) 113
TABLE 39 BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2021–2026 (USD MILLION) 113
6.2.3.2 Vacuum tubes 113
6.2.3.2.1 Advantages of vacuum tubes to account for the larger market share 113
TABLE 40 VACUUM TUBES AVAILABLE IN THE MARKET 113
TABLE 41 VACUUM TUBES MARKET, BY REGION, 2017–2020 (USD MILLION) 114
TABLE 42 VACUUM TUBES MARKET, BY REGION, 2021–2026 (USD MILLION) 114
6.2.3.3 Non-vacuum tubes 114
6.2.3.3.1 Cost constraints to drive consumer preference towards non-vacuum tubes 114
TABLE 43 NON-VACUUM TUBES AVAILABLE IN THE MARKET 115
TABLE 44 NON-VACUUM TUBES MARKET, BY REGION, 2017–2020 (USD MILLION) 115
TABLE 45 NON-VACUUM TUBES MARKET, BY REGION, 2021–2026 (USD MILLION) 116
6.3 NEEDLES & SYRINGES 116
6.3.1 INCREASING NUMBER OF BLOOD COLLECTION PROCEDURES TO DRIVE MARKET GROWTH 116
TABLE 46 NEEDLES & SYRINGES AVAILABLE IN THE MARKET 116
TABLE 47 BLOOD COLLECTION NEEDLES & SYRINGES MARKET, BY REGION,
2017–2020 (USD MILLION) 117
TABLE 48 BLOOD COLLECTION NEEDLES & SYRINGES MARKET, BY REGION,
2021–2026 (USD MILLION) 117
6.4 BLOOD BAGS 118
6.4.1 INCREASE IN BLOOD DONATIONS TO SUSTAIN PURCHASE AND USE OF BLOOD BAGS 118
TABLE 49 BLOOD BAGS AVAILABLE IN THE MARKET 118
6.4.2 IMPACT OF COVID-19 ON THE BLOOD BAGS MARKET 119
6.4.2.1 Standard blood bags 119
6.4.2.2 Inline systems 120
6.4.2.3 Filters 120
TABLE 50 BLOOD BAGS MARKET, BY TYPE, 2017–2020 (USD MILLION) 120
TABLE 51 BLOOD BAGS MARKET, BY TYPE, 2021–2026 (USD MILLION) 120
TABLE 52 BLOOD COLLECTION BAGS MARKET, BY REGION, 2017–2020 (USD MILLION) 121
TABLE 53 BLOOD COLLECTION BAGS MARKET, BY REGION, 2021–2026 (USD MILLION) 121
6.5 BLOOD COLLECTION SYSTEMS/MONITORS 121
6.5.1 RISING PREVALENCE OF BLOOD DISORDERS AND DEMAND FOR BLOOD TO ENSURE THE USE OF COLLECTION SYSTEMS 121
TABLE 54 BLOOD COLLECTION SYSTEMS/MONITORS AVAILABLE IN THE MARKET 122
6.5.2 IMPACT OF COVID-19 ON BLOOD COLLECTION SYSTEMS/MONITORS MARKET 123
TABLE 55 BLOOD COLLECTION SYSTEMS/MONITORS MARKET, BY REGION,
2017–2020 (USD MILLION) 123
TABLE 56 BLOOD COLLECTION SYSTEMS/MONITORS MARKET, BY REGION,
2021–2026 (USD MILLION) 123
6.6 LANCETS 124
6.6.1 RISING GOVERNMENT SUPPORT FOR LANCET TO INCREASE THEIR ADOPTION 124
TABLE 57 LANCETS AVAILABLE IN THE MARKET 124
TABLE 58 BLOOD COLLECTION LANCETS MARKET, BY REGION,
2017–2020 (USD MILLION) 125
TABLE 59 BLOOD COLLECTION LANCETS MARKET, BY REGION,
2021–2026 (USD MILLION) 125
7 BLOOD COLLECTION DEVICES MARKET, BY METHOD 126
7.1 INTRODUCTION 127
TABLE 60 BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2017–2020 (USD MILLION) 127
TABLE 61 BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2021–2026 (USD MILLION) 127
7.2 MANUAL BLOOD COLLECTION 127
7.2.1 MANUAL BLOOD COLLECTION TO HOLD THE LARGEST MARKET SHARE 127
7.2.2 IMPACT OF COVID-19 ON THE MANUAL BLOOD COLLECTION DEVICES MARKET 128
TABLE 62 MANUAL BLOOD COLLECTION DEVICES MARKET, BY REGION,
2017–2020 (USD MILLION) 128
TABLE 63 MANUAL BLOOD COLLECTION DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 129
7.3 AUTOMATED BLOOD COLLECTION 129
7.3.1 HIGHER SAFETY AND EFFICIENCY TO DRIVE DEMAND FOR AUTOMATED COLLECTION 129
7.3.2 MARKET TRENDS 129
7.3.3 IMPACT OF COVID-19 ON THE AUTOMATED BLOOD COLLECTION DEVICES MARKET 130
TABLE 64 AUTOMATED BLOOD COLLECTION DEVICES MARKET, BY REGION,
2017–2020 (USD MILLION) 130
TABLE 65 AUTOMATED BLOOD COLLECTION DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 131
8 BLOOD COLLECTION DEVICES MARKET, BY APPLICATION 132
8.1 INTRODUCTION 133
TABLE 66 BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2017–2020 (USD MILLION) 133
TABLE 67 BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 133
 
8.2 DIAGNOSTICS 133
8.2.1 RISING DISEASE INCIDENCE AND ADOPTION OF POINT-OF-CARE TESTING TO DRIVE MARKET GROWTH 133
8.2.2 IMPACT OF COVID-19 ON THE DIAGNOSTIC BLOOD COLLECTION DEVICES MARKET 135
TABLE 68 DIAGNOSTIC BLOOD COLLECTION DEVICES MARKET, BY REGION,
2017–2020 (USD MILLION) 135
TABLE 69 DIAGNOSTIC BLOOD COLLECTION DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 135
8.3 THERAPEUTICS 136
8.3.1 NORTH AMERICA TO DOMINATE THE THERAPEUTIC BLOOD COLLECTION DEVICES MARKET 136
8.3.2 IMPACT OF COVID-19 ON THE THERAPEUTIC BLOOD COLLECTION DEVICES MARKET 136
TABLE 70 THERAPEUTIC BLOOD COLLECTION DEVICES MARKET, BY REGION,
2017–2020 (USD MILLION) 136
TABLE 71 THERAPEUTIC BLOOD COLLECTION DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 137
9 BLOOD COLLECTION DEVICES MARKET, BY END USER 138
9.1 INTRODUCTION 139
TABLE 72 BLOOD COLLECTION DEVICES MARKET, BY END USER,
2017–2020 (USD MILLION) 139
TABLE 73 BLOOD COLLECTION DEVICES MARKET, BY END USER,
2021–2026 (USD MILLION) 139
9.2 HOSPITALS, ASC, & NURSING HOMES 140
9.2.1 INCREASING DISEASE AND TRAUMA INCIDENCE TO DRIVE MARKET GROWTH 140
TABLE 74 NUMBER OF SURGICAL PROCEDURES, 2015 VS. 2020 (MILLION) 140
TABLE 75 BLOOD COLLECTION DEVICES MARKET FOR HOSPITALS, AMBULATORY SURGICAL CENTERS, & NURSING HOMES, BY REGION,
2017–2020 (USD MILLION) 141
TABLE 76 BLOOD COLLECTION DEVICES MARKET FOR HOSPITALS, AMBULATORY SURGICAL CENTERS, & NURSING HOMES, BY REGION,
2021–2026 (USD MILLION) 141
9.3 DIAGNOSTIC & PATHOLOGY LABORATORIES 142
9.3.1 MARKET GROWTH TO WITNESS RISING DISEASE INCIDENCE AND INCREASING TESTING VOLUMES 142
TABLE 77 BLOOD COLLECTION DEVICES MARKET FOR DIAGNOSTIC & PATHOLOGY LABORATORIES, BY REGION, 2017–2020 (USD MILLION) 142
TABLE 78 BLOOD COLLECTION DEVICES MARKET FOR DIAGNOSTIC & PATHOLOGY LABORATORIES, BY REGION, 2021–2026 (USD MILLION) 143
9.4 BLOOD BANKS 143
9.4.1 RISE IN BLOOD DONATION VOLUMES TO DRIVE THE MARKET FOR BLOOD BANKS 143
TABLE 79 BLOOD COLLECTION DEVICES MARKET FOR BLOOD BANKS, BY REGION, 2017–2020 (USD MILLION) 144
TABLE 80 BLOOD COLLECTION DEVICES MARKET FOR BLOOD BANKS, BY REGION, 2021–2026 (USD MILLION) 144
9.5 OTHER END USERS 145
TABLE 81 BLOOD COLLECTION DEVICES MARKET FOR OTHER END USERS, BY REGION, 2017–2020 (USD MILLION) 145
TABLE 82 BLOOD COLLECTION DEVICES MARKET FOR OTHER END USERS, BY REGION, 2021–2026 (USD MILLION) 145
10 BLOOD COLLECTION DEVICES MARKET, BY REGION 146
10.1 INTRODUCTION 147
TABLE 83 BLOOD COLLECTION DEVICES MARKET, BY REGION,
2017–2020 (USD MILLION) 147
TABLE 84 BLOOD COLLECTION DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 147
10.2 NORTH AMERICA 148
FIGURE 33 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET SNAPSHOT 149
TABLE 85 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2017–2020 (USD MILLION) 149
TABLE 86 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2021–2026 (USD MILLION) 150
TABLE 87 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2017–2020 (USD MILLION) 150
TABLE 88 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2021–2026 (USD MILLION) 150
TABLE 89 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2017–2020 (USD MILLION) 151
TABLE 90 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2021–2026 (USD MILLION) 151
TABLE 91 NORTH AMERICA: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET,
BY TYPE, 2017–2020 (USD MILLION) 151
TABLE 92 NORTH AMERICA: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET,
BY TYPE, 2021–2026 (USD MILLION) 152
TABLE 93 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2017–2020 (USD MILLION) 152
TABLE 94 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2021–2026 (USD MILLION) 152
TABLE 95 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2017–2020 (USD MILLION) 153
TABLE 96 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2021–2026 (USD MILLION) 153
TABLE 97 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2017–2020 (USD MILLION) 153
TABLE 98 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2021–2026 (USD MILLION) 154
TABLE 99 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2017–2020 (USD MILLION) 154
TABLE 100 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2021–2026 (USD MILLION) 154
 
10.2.1 US 155
10.2.1.1 US to be the largest market for blood collection devices both globally and in North America 155
TABLE 101 INCIDENCE OF VARIOUS CANCERS IN THE US, 2018 VS. 2025 156
TABLE 102 US: KEY MACROINDICATORS 157
10.2.1.2 Impact of COVID-19 on the market in the US 157
TABLE 103 US: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 157
TABLE 104 US: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 158
TABLE 105 US: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2017–2020 (USD MILLION) 158
TABLE 106 US: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2021–2026 (USD MILLION) 158
TABLE 107 US: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE,
2017–2020 (USD MILLION) 159
TABLE 108 US: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE,
2021–2026 (USD MILLION) 159
TABLE 109 US: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2017–2020 (USD MILLION) 159
TABLE 110 US: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2021–2026 (USD MILLION) 160
TABLE 111 US: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2017–2020 (USD MILLION) 160
TABLE 112 US: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2021–2026 (USD MILLION) 160
TABLE 113 US: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2017–2020 (USD MILLION) 160
TABLE 114 US: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 161
TABLE 115 US: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2017–2020 (USD MILLION) 161
TABLE 116 US: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2021–2026 (USD MILLION) 161
10.2.2 CANADA 162
10.2.2.1 Growing volume of surgical procedures and the rising burden of cancer to support market growth 162
TABLE 117 SURGICAL PROCEDURES PERFORMED IN CANADA, 2019 162
TABLE 118 CANADA: KEY MACROINDICATORS 163
10.2.2.2 Impact of COVID-19 on the market in Canada 163
TABLE 119 CANADA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 163
TABLE 120 CANADA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 164
TABLE 121 CANADA: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2017–2020 (USD MILLION) 164
TABLE 122 CANADA: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2021–2026 (USD MILLION) 164
TABLE 123 CANADA: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017–2020 (USD MILLION) 165
TABLE 124 CANADA: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2021–2026 (USD MILLION) 165
TABLE 125 CANADA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2017–2020 (USD MILLION) 165
TABLE 126 CANADA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2021–2026 (USD MILLION) 166
TABLE 127 CANADA: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2017–2020 (USD MILLION) 166
TABLE 128 CANADA: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2021–2026 (USD MILLION) 166
TABLE 129 CANADA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2017–2020 (USD MILLION) 167
TABLE 130 CANADA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 167
TABLE 131 CANADA: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2017–2020 (USD MILLION) 167
TABLE 132 CANADA: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2021–2026 (USD MILLION) 168
10.3 EUROPE 168
TABLE 133 EUROPE: BLOOD COLLECTION DEVICES MARKET, BY COUNTRY,
2017–2020 (USD MILLION) 169
TABLE 134 EUROPE: BLOOD COLLECTION DEVICES MARKET, BY COUNTRY,
2021–2026 (USD MILLION) 169
TABLE 135 EUROPE: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 170
TABLE 136 EUROPE: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 170
TABLE 137 EUROPE: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2017–2020 (USD MILLION) 170
TABLE 138 EUROPE: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2021–2026 (USD MILLION) 171
TABLE 139 EUROPE: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017–2020 (USD MILLION) 171
TABLE 140 EUROPE: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2021–2026 (USD MILLION) 171
TABLE 141 EUROPE: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2017–2020 (USD MILLION) 172
TABLE 142 EUROPE: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2021–2026 (USD MILLION) 172
TABLE 143 EUROPE: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2017–2020 (USD MILLION) 172
TABLE 144 EUROPE: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2021–2026 (USD MILLION) 173
TABLE 145 EUROPE: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2017–2020 (USD MILLION) 173
TABLE 146 EUROPE: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 173
TABLE 147 EUROPE: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2017–2020 (USD MILLION) 174
TABLE 148 EUROPE: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2021–2026 (USD MILLION) 174
10.3.1 GERMANY 174
10.3.1.1 Germany to hold the largest share of the market in Europe 174
TABLE 149 SURGICAL PROCEDURES PERFORMED IN GERMANY, 2019 175
TABLE 150 GERMANY: KEY MACROINDICATORS 175
10.3.1.2 Impact of COVID-19 on the market in Germany 176
TABLE 151 GERMANY: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 176
TABLE 152 GERMANY: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 176
TABLE 153 GERMANY: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2017–2020 (USD MILLION) 177
TABLE 154 GERMANY: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2021–2026 (USD MILLION) 177
TABLE 155 GERMANY: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017–2020 (USD MILLION) 177
TABLE 156 GERMANY: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2021–2026 (USD MILLION) 178
TABLE 157 GERMANY: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2017–2020 (USD MILLION) 178
TABLE 158 GERMANY: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2021–2026 (USD MILLION) 178
TABLE 159 GERMANY: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2017–2020 (USD MILLION) 179
TABLE 160 GERMANY: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2021–2026 (USD MILLION) 179
TABLE 161 GERMANY: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2017–2020 (USD MILLION) 179
TABLE 162 GERMANY: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 180
TABLE 163 GERMANY: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2017–2020 (USD MILLION) 180
TABLE 164 GERMANY: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2021–2026 (USD MILLION) 180
10.3.2 FRANCE 181
10.3.2.1 Favorable initiatives and the development of diagnostic tests to showcase growth trajectory in France 181
TABLE 165 SURGICAL PROCEDURES PERFORMED IN FRANCE, 2019 181
TABLE 166 FRANCE: KEY INDICATORS 182
10.3.2.2 Impact of COVID-19 on the market in France 182
TABLE 167 FRANCE: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 182
TABLE 168 FRANCE: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 183
TABLE 169 FRANCE: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2017–2020 (USD MILLION) 183
TABLE 170 FRANCE: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2021–2026 (USD MILLION) 183
TABLE 171 FRANCE: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017–2020 (USD MILLION) 184
TABLE 172 FRANCE: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2021–2026 (USD MILLION) 184
TABLE 173 FRANCE: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2017–2020 (USD MILLION) 184
TABLE 174 FRANCE: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2021–2026 (USD MILLION) 185
TABLE 175 FRANCE: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2017–2020 (USD MILLION) 185
TABLE 176 FRANCE: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2021–2026 (USD MILLION) 185
TABLE 177 FRANCE: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2017–2020 (USD MILLION) 186
TABLE 178 FRANCE: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 186
TABLE 179 FRANCE: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2017–2020 (USD MILLION) 186
TABLE 180 FRANCE: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2021–2026 (USD MILLION) 187
10.3.3 UK 187
10.3.3.1 Government support to prevent transmission of HIV, chronic diseases, and other infections to drive market growth 187
TABLE 181 SURGICAL PROCEDURES PERFORMED IN THE UK, 2019 188
TABLE 182 UK: KEY MACROINDICATORS 188
10.3.3.2 Impact of COVID-19 on the market in the UK 188
TABLE 183 UK: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 189
TABLE 184 UK: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 189
TABLE 185 UK: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2017–2020 (USD MILLION) 189
TABLE 186 UK: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2021–2026 (USD MILLION) 190
TABLE 187 UK: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE,
2017–2020 (USD MILLION) 190
TABLE 188 UK: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE,
2021–2026 (USD MILLION) 190
TABLE 189 UK: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2017–2020 (USD MILLION) 191
TABLE 190 UK: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2021–2026 (USD MILLION) 191
TABLE 191 UK: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2017–2020 (USD MILLION) 191
TABLE 192 UK: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2021–2026 (USD MILLION) 191
TABLE 193 UK: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2017–2020 (USD MILLION) 192
TABLE 194 UK: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 192
TABLE 195 UK: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2017–2020 (USD MILLION) 192
TABLE 196 UK: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2021–2026 (USD MILLION) 193
10.3.4 ITALY 193
10.3.4.1 Low healthcare expenditure and slow growth in the healthcare sector to affect the market growth 193
TABLE 197 DIFFERENT SURGICAL PROCEDURES PERFORMED IN ITALY IN 2019 193
TABLE 198 ITALY: KEY INDICATORS 194
10.3.4.2 Impact of COVID-19 on the market in Italy 194
TABLE 199 ITALY: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 194
TABLE 200 ITALY: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 194
TABLE 201 ITALY: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2017–2020 (USD MILLION) 195
TABLE 202 ITALY: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2021–2026 (USD MILLION) 195
TABLE 203 ITALY: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017–2020 (USD MILLION) 195
TABLE 204 ITALY: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2021–2026 (USD MILLION) 196
TABLE 205 ITALY: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2017–2020 (USD MILLION) 196
TABLE 206 ITALY: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2021–2026 (USD MILLION) 196
TABLE 207 ITALY: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2017–2020 (USD MILLION) 197
TABLE 208 ITALY: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2021–2026 (USD MILLION) 197
TABLE 209 ITALY: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2017–2020 (USD MILLION) 197
TABLE 210 ITALY: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 197
TABLE 211 ITALY: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2017–2020 (USD MILLION) 198
TABLE 212 ITALY: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2021–2026 (USD MILLION) 198
10.3.5 SPAIN 198
10.3.5.1 Increasing adoption of NAT technology to support market growth 198
TABLE 213 DIFFERENT SURGICAL PROCEDURES PERFORMED IN SPAIN IN 2019 199
TABLE 214 SPAIN: KEY INDICATORS 199
10.3.5.2 Impact of COVID-19 on the market in Spain 199
TABLE 215 SPAIN: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 200
TABLE 216 SPAIN: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 200
TABLE 217 SPAIN: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2017–2020 (USD MILLION) 200
TABLE 218 SPAIN: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2021–2026 (USD MILLION) 201
TABLE 219 SPAIN: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017–2020 (USD MILLION) 201
TABLE 220 SPAIN: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2021–2026 (USD MILLION) 201
TABLE 221 SPAIN: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2017–2020 (USD MILLION) 202
TABLE 222 SPAIN: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2021–2026 (USD MILLION) 202
TABLE 223 SPAIN: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2017–2020 (USD MILLION) 202
TABLE 224 SPAIN: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2021–2026 (USD MILLION) 202
TABLE 225 SPAIN: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2017–2020 (USD MILLION) 203
TABLE 226 SPAIN: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 203
TABLE 227 SPAIN: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2017–2020 (USD MILLION) 203
TABLE 228 SPAIN: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2021–2026 (USD MILLION) 204
10.3.6 REST OF EUROPE 204
TABLE 229 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2020 (% OF GDP) 204
TABLE 230 PERCENTAGE OF POPULATION AGED 60 YEARS OR OVER, 2017 VS. 2050 205
TABLE 231 SURGICAL PROCEDURES PERFORMED IN SWITZERLAND, 2019 205
TABLE 232 SURGICAL PROCEDURES PERFORMED IN BELGIUM, 2019 205
TABLE 233 ROE: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 206
TABLE 234 ROE: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 206
TABLE 235 ROE: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2017–2020 (USD MILLION) 206
TABLE 236 ROE: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2021–2026 (USD MILLION) 207
TABLE 237 ROE: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE,
2017–2020 (USD MILLION) 207
TABLE 238 ROE: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE,
2021–2026 (USD MILLION) 207
TABLE 239 ROE: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2017–2020 (USD MILLION) 208
TABLE 240 ROE: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2021–2026 (USD MILLION) 208
TABLE 241 ROE: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2017–2020 (USD MILLION) 208
TABLE 242 ROE: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2021–2026 (USD MILLION) 208
TABLE 243 ROE: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2017–2020 (USD MILLION) 209
TABLE 244 ROE: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 209
TABLE 245 ROE: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2017–2020 (USD MILLION) 209
TABLE 246 ROE: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2021–2026 (USD MILLION) 210

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107
 
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170
 
10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31
 
3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56
 
7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88
 
9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127